AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Norledge, BV Lambeir, AM Abagyan, RA Rottmann, A Fernandez, AM Filimonov, VV Peter, MG Wierenga, RK
Citation: Bv. Norledge et al., Modeling, mutagenesis, and structural studies on the fully conserved phosphate-binding loop (loop 8) of triosephosphate isomerase: Toward a new substrate specificity, PROTEINS, 42(3), 2001, pp. 383-389

Authors: Lambeir, AM Proost, P Durinx, C Bal, G Senten, K Augustyns, K Scharpe, S Van Damme, J De Meester, I
Citation: Am. Lambeir et al., Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidaseIV reveals a striking selectivity within the chemokine family, J BIOL CHEM, 276(32), 2001, pp. 29839-29845

Authors: Lambeir, AM Durinx, C Proost, P Van Damme, J Scharpe, S De Meester, I
Citation: Am. Lambeir et al., Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion, FEBS LETTER, 507(3), 2001, pp. 327-330

Authors: Kursula, I Partanen, S Lambeir, AM Antonov, DM Augustyns, K Wierenga, RK
Citation: I. Kursula et al., Structural determinants for ligand binding and catalysis of triosephosphate isomerase, EUR J BIOCH, 268(19), 2001, pp. 5189-5196

Authors: Proost, P Schutyser, E Menten, P Struyf, S Wuyts, A Opdenakker, G Detheux, M Parmentier, M Durinx, C Lambeir, AM Neyts, J Liekens, S Maudgal, PC Billiau, A Van Damme, J
Citation: P. Proost et al., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties, BLOOD, 98(13), 2001, pp. 3554-3561

Authors: Lambeir, AM Backmann, J Ruiz-Sanz, J Filimonov, V Nielsen, JE Kursula, I Norledge, BV Wierenga, RK
Citation: Am. Lambeir et al., The ionization of a buried glutamic acid is thermodynamically linked to the stability of Leishmania mexicana triose phosphate isomerase, EUR J BIOCH, 267(9), 2000, pp. 2516-2524

Authors: Durinx, C Lambeir, AM Bosmans, E Falmagne, JB Berghmans, R Haemers, A Scharpe, S De Meester, I
Citation: C. Durinx et al., Molecular characterization of dipeptidyl peptidase activity in serum - Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides, EUR J BIOCH, 267(17), 2000, pp. 5608-5613

Authors: Zhang, XY De Meester, I Lambeir, AM Dillen, L Van Dongen, W Esmans, EL Haemers, A Scharpe, S Claeys, M
Citation: Xy. Zhang et al., Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquidchromatography electrospray mass spectrometry, J MASS SPEC, 34(4), 1999, pp. 255-263

Authors: Augustyns, K Bal, G Thonus, G Belyaev, A Zhang, XM Bollaert, W Lambeir, AM Durinx, C Goossens, F Haemers, A
Citation: K. Augustyns et al., The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors, CURR MED CH, 6(4), 1999, pp. 311-327

Authors: Williams, JC Zeelen, JP Neubauer, G Vriend, G Backmann, J Michels, PAM Lambeir, AM Wierenga, RK
Citation: Jc. Williams et al., Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power, PROTEIN ENG, 12(3), 1999, pp. 243-250

Authors: Belyaev, A Zhang, XM Augustyns, K Lambeir, AM De Meester, I Vedernikova, I Scharpe, S Haemers, A
Citation: A. Belyaev et al., Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors, J MED CHEM, 42(6), 1999, pp. 1041-1052

Authors: Proost, P Struyf, S Schols, D Opdenakker, G Sozzani, S Allavena, P Mantovani, A Augustyns, K Bal, G Haemers, A Lambeir, AM Scharpe, S Van Damme, J De Meester, I
Citation: P. Proost et al., Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IVbeyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction, J BIOL CHEM, 274(7), 1999, pp. 3988-3993
Risultati: 1-12 |